These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34375688)

  • 21. [The inhibitory effects of dumb-bell decoy oligodeoxynucleotides targeting NF-kappaB on the growth of multiple myeloma cells and IL-6 expression].
    Jiang HL; Xue WJ; Liu H; Chen W
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jan; 22(1):47-50. PubMed ID: 16388744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nuclear factor-kappaB decoy oligodeoxynucleotides prevent acute lung injury in mice with cecal ligation and puncture-induced sepsis.
    Matsuda N; Hattori Y; Jesmin S; Gando S
    Mol Pharmacol; 2005 Apr; 67(4):1018-25. PubMed ID: 15576632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of TNFalpha production in LPS induced liver failure in mice after intravenous injection of cationic liposomes/NFkappaB decoy complex.
    Higuchi Y; Kawakami S; Oka M; Yamashita F; Hashida M
    Pharmazie; 2006 Feb; 61(2):144-7. PubMed ID: 16526563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of NF-kappaB signaling by decoy oligodeoxynucleotides.
    Isomura I; Morita A
    Microbiol Immunol; 2006; 50(8):559-63. PubMed ID: 16924140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of decoy-oligodeoxynucleotides on expression of inflammation mediators in pMPhi cells from rats.
    Guo H; Liang HP; Lu FL; Xu X; An B; Hao TZ; Wang FL; Yang WJ
    Chin J Traumatol; 2003 Dec; 6(6):363-9. PubMed ID: 14642058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of neointimal formation after angioplasty using nuclear factor-κB decoy oligodeoxynucleotide-coated balloon catheter in rabbit model.
    Miyake T; Ihara S; Miyake T; Tsukada Y; Watanabe H; Matsuda H; Kiguchi H; Tsujimoto H; Nakagami H; Morishita R
    Circ Cardiovasc Interv; 2014 Dec; 7(6):787-96. PubMed ID: 25406205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Augmented regeneration of partial liver allograft induced by nuclear factor-kappaB decoy oligodeoxynucleotides-modified dendritic cells.
    Xu MQ; Suo YP; Gong JP; Zhang MM; Yan LN
    World J Gastroenterol; 2004 Feb; 10(4):573-8. PubMed ID: 14966919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcription factor oligodeoxynucleotides to NF-kappaB inhibit transcription of IL-8 in bronchial cells.
    Bezzerri V; Borgatti M; Nicolis E; Lampronti I; Dechecchi MC; Mancini I; Rizzotti P; Gambari R; Cabrini G
    Am J Respir Cell Mol Biol; 2008 Jul; 39(1):86-96. PubMed ID: 18258920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of TNF-alpha, induced cytokine and adhesion molecule. Expression in glomerular cells in vitro and in vivo by transcription factor decoy for NFkappaB.
    Tomita N; Morishita R; Tomita S; Kaneda Y; Higaki J; Ogihara T; Horiuchi M
    Exp Nephrol; 2001; 9(3):181-90. PubMed ID: 11340302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcriptional regulation of NF-kappaB by ring type decoy oligodeoxynucleotide in an animal model of nephropathy.
    Kim KH; Lee ES; Cha SH; Park JH; Park JS; Chang YC; Park KK
    Exp Mol Pathol; 2009 Apr; 86(2):114-20. PubMed ID: 19118545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Codelivery of NF-kappaB decoy-related oligodeoxynucleotide improves LPD-mediated systemic gene transfer.
    Tan Y; Zhang JS; Huang L
    Mol Ther; 2002 Dec; 6(6):804-12. PubMed ID: 12498776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of Allergic Response by Intranasal Selective NF-κB Decoy Oligodeoxynucleotides in a Murine Model of Allergic Rhinitis.
    Wee JH; Zhang YL; Rhee CS; Kim DY
    Allergy Asthma Immunol Res; 2017 Jan; 9(1):61-69. PubMed ID: 27826963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exosome-mediated delivery of RBP-J decoy oligodeoxynucleotides ameliorates hepatic fibrosis in mice.
    He F; Li WN; Li XX; Yue KY; Duan JL; Ruan B; Liu JJ; Song P; Yue ZS; Tao KS; Wang L
    Theranostics; 2022; 12(4):1816-1828. PubMed ID: 35198075
    [No Abstract]   [Full Text] [Related]  

  • 34. [The effects of nuclear factor kappa B decoy oligodeoxynucleotides on ciglitazone-induced differentiation of lung cancer cells A549].
    Zhang HL; Zhang ZX; Xu YJ
    Zhonghua Nei Ke Za Zhi; 2004 Mar; 43(3):201-4. PubMed ID: 15059376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modification of decoy oligodeoxynucleotides to achieve the stability and therapeutic efficacy.
    Osako MK; Nakagami H; Morishita R
    Curr Top Med Chem; 2012; 12(15):1603-7. PubMed ID: 22762556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Regulation of tissue factor expression in brain microvascular endothelial cells by PLA nanoparticles coating NF-kappaB decoy oligonucleotides].
    Hu Y; Wang HF; Sun WQ; Xie CS; Wei WN; Zheng JE; Yao JX
    Zhonghua Xue Ye Xue Za Zhi; 2005 Sep; 26(9):534-8. PubMed ID: 16468330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intracellular distribution of NFkappaB decoy and its inhibitory effect on TNFalpha production by LPS stimulated RAW 264.7 cells.
    Higuchi Y; Kawakami S; Nishikawa M; Yamashita F; Hashida M
    J Control Release; 2005 Oct; 107(2):373-82. PubMed ID: 16125268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Development of cell-selective targeting systems of NFkappaB decoy for inflammation therapy].
    Higuchi Y; Kawakami S; Hashida M
    Yakugaku Zasshi; 2008 Feb; 128(2):209-18. PubMed ID: 18239368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of chimeric decoy oligodeoxynucleotide in the regulation of transcription factors NF-κB and Sp1 in an animal model of atherosclerosis.
    Lee WR; Kim KH; An HJ; Park YY; Kim KS; Lee CK; Min BK; Park KK
    Basic Clin Pharmacol Toxicol; 2013 Apr; 112(4):236-43. PubMed ID: 23107157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting transcription factor activity as a strategy to inhibit pro-inflammatory genes involved in cystic fibrosis: decoy oligonucleotides and low-molecular weight compounds.
    Cabrini G; Bezzerri V; Mancini I; Nicolis E; Dechecchi MC; Tamanini A; Lampronti I; Piccagli L; Bianchi N; Borgatti M; Gambari R
    Curr Med Chem; 2010; 17(35):4392-404. PubMed ID: 20939807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.